These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7021099)

  • 21. [Withdrawal of prednisone from a triple combination of immunosuppressive agents after kidney transplantation].
    Matl I; Lácha J; Lodererová A; Símová M; Teplan V; Lánská V; Vítko S
    Cas Lek Cesk; 2000 Mar; 139(4):115-9. PubMed ID: 10838741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of the renal allograft recipient: immunosuppressive protocols for long-term success.
    Delmonico FL; Tolkoff-Rubin N; Auchincloss H; Williams WW; Fang LT; Bazari H; Farrell ML; Cosimi AB
    Clin Transplant; 1994 Feb; 8(1):34-9. PubMed ID: 8136565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five years' experience with quadruple sequential immunosuppression.
    Fischbach M; Wolff P; Tongio MM; Boudjema K; Christmann D; Steib A; Sauvage P; Desprez P; Mengus L; Simeoni U
    Transplant Proc; 1994 Feb; 26(1):17. PubMed ID: 8108924
    [No Abstract]   [Full Text] [Related]  

  • 25. Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up.
    Jonas S; Neuhaus R; Junge G; Klupp J; Theruvat T; Langrehr JM; Settmacher U; Neuhaus P
    Int Immunopharmacol; 2005 Jan; 5(1):125-8. PubMed ID: 15589470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal allograft function and histology in children on triple immunosuppression based on individual pharmacokinetically determined cyclosporine administration.
    Laine J; Hoppu K; Holmberg C
    Transplant Proc; 1994 Oct; 26(5):2775-6. PubMed ID: 7940874
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M; Latter DA; Loertscher R
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adverse effects of immunosuppression following kidney allotransplantation and data on the mechanism of infectious complications].
    Tomilina NA; L'vitsina GM
    Vestn Akad Med Nauk SSSR; 1973; 28(8):64-6. PubMed ID: 4585256
    [No Abstract]   [Full Text] [Related]  

  • 29. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients.
    Câmara NO; Dias MF; Pacheco-Silva A
    Clin Transplant; 2004 Aug; 18(4):450-5. PubMed ID: 15233825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants.
    Lucan M; Iacob G; Lucan C; Lăpuşan C; Munteanu A; Sîrbu S
    Transplant Proc; 2004 Mar; 36(2 Suppl):177S-180S. PubMed ID: 15041332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate for rejection prophylaxis after heart transplantation.
    Taylor DO; Olsen SL; Ensley RD; Renlund DG
    J Heart Lung Transplant; 1995; 14(5):950-4. PubMed ID: 8800732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azathioprine and prednisone.
    Pierce JC; Sloane CE
    Transplant Proc; 1972 Dec; 4(4):457-60. PubMed ID: 4566785
    [No Abstract]   [Full Text] [Related]  

  • 33. Profibrotic cytokines and lymphocyte proliferation in stable renal allograft recipients treated with or without cyclosporine A.
    Waiser J; Schneider M; Eljazyfer S; Slowinski T; Glander P; Einecke G; Budde K; Neumayer HH; Böhler T
    Clin Immunol; 2006 Apr; 119(1):59-66. PubMed ID: 16451828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
    Jazzar A; Fagiuoli S; Sisson S; Zuhdi N; Cooper DK
    Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternate-day prednisone therapy after renal transplantation.
    Reed WP; Lucas ZJ; Cohn R
    Lancet; 1970 Apr; 1(7650):747-9. PubMed ID: 4191248
    [No Abstract]   [Full Text] [Related]  

  • 36. Steroid withdrawal after renal transplantation.
    Schulak JA; Hricik DE
    Clin Transplant; 1994 Apr; 8(2 Pt 2):211-6. PubMed ID: 8019038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of sirolimus treatment in kidney allograft recipients with prolonged cold ischemia times: 5-year outcomes.
    Boratynska M; Banasik M; Patrzalek D; Klinger M
    Exp Clin Transplant; 2008 Mar; 6(1):59-66. PubMed ID: 18405247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal homotransplantation in infants and children with the hemolytic-uremic syndrome.
    Cerilli GJ; Nelsen C; Dorfmann L
    Surgery; 1972 Jan; 71(1):66-71. PubMed ID: 4550237
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunosuppressive regimens and their effects on renal allograft outcome.
    Katznelson S; Cecka JM
    Clin Transpl; 1996; ():361-71. PubMed ID: 9286582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.